Aethlon Medical (NASDAQ:AEMD) Earns Sell Rating from Analysts at StockNews.com

by · The Markets Daily

Equities research analysts at StockNews.com began coverage on shares of Aethlon Medical (NASDAQ:AEMD – Get Free Report) in a research report issued to clients and investors on Thursday. The brokerage set a “sell” rating on the medical equipment provider’s stock.

Separately, HC Wainwright reissued a “buy” rating and issued a $7.00 price target on shares of Aethlon Medical in a research report on Friday, November 15th.

Check Out Our Latest Research Report on AEMD

Aethlon Medical Price Performance

Shares of Aethlon Medical stock opened at $0.61 on Thursday. Aethlon Medical has a 52-week low of $0.24 and a 52-week high of $2.35. The firm has a market capitalization of $8.46 million, a PE ratio of -0.21 and a beta of 1.79. The company’s fifty day moving average price is $0.42 and its two-hundred day moving average price is $0.43.

Aethlon Medical Company Profile

(Get Free Report)

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.

Featured Articles